The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial.
 
Masatoshi Kudo
Honoraria - Ajinomoto; Bayer; Eisai; MSD
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; MSD; Taiho Pharmaceutical
Research Funding - Abbvie; Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Otsuka; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda
 
Kazuomi Ueshima
Honoraria - Bayer
 
Masafumi Ikeda
Honoraria - Abbott Japan; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly Japan; Nippon Kayaku; Novartis; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer Yakuhin; Bristol-Myers Squibb; Eisai; Kyowa Hakko Kirin; Lilly Japan; NanoCarrier
Research Funding - ASLAN Pharmaceuticals; AstraZeneca; Baxter; Bayer Yakuhin; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Eisai; Kowa; Kowa; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; NanoCarrier; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical; Zeria Pharmaceutical
 
Takuji Torimura
No Relationships to Disclose
 
Nobukazu Tanabe
No Relationships to Disclose
 
Hiroshi Aikata
Honoraria - Bayer
 
Namiki Izumi
Honoraria - Bayer; MSD
Speakers' Bureau - Abbvie; Bayer; Gilead Sciences; Otsuka
 
Takahiro Yamasaki
No Relationships to Disclose
 
Shunsuke Nojiri
No Relationships to Disclose
 
Keisuke Hino
Speakers' Bureau - Bristol-Myers Squibb; Merck; Sharp healthcare
Research Funding - Bristol-Myers Squibb; Gilead Sciences
 
Hidetaka Tsumura
No Relationships to Disclose
 
Teiji Kuzuya
No Relationships to Disclose
 
Norio Isoda
Research Funding - Abbvie
 
Kohichiroh Yasui
No Relationships to Disclose
 
Kenichi Yoshimura
No Relationships to Disclose
 
Takuji Okusaka
Honoraria - AstraZeneca; Baxter; Bayer Yakuhin; Bristol-Myers Squibb; Celgene; Chugai Pharma; Dainippon Sumitomo Pharma; EA Pharma; Eisai; Fujifilm; Lilly Japan; Merck Serono; Nippon Chemiphar; Nippon Kayaku; Nobelpharma; Novartis; One Medical Oscar; Pfizer; Taiho Pharmaceutical; Teijin Pharma
Consulting or Advisory Role - Daiichi Sankyo; Dainippon Sumitomo Pharma; Lilly Japan; Nippon Boehringer Ingelheim; Taiho Pharmaceutical; Zeria Pharmaceutical
Research Funding - AstraZeneca; Baxter; Bayer Yakuhin; Chugai Pharma; Dainippon Sumitomo Pharma; Eisai; Kowa; Kyowa Hakko Kirin; Lilly; Merck Serono; NanoCarrier; Nippon Boehringer Ingelheim; Novartis; One Medical Oscar; Pfizer; Taiho Pharmaceutical; Yakult Honsha
 
Junji Furuse
No Relationships to Disclose
 
Norihiro Kokudo
No Relationships to Disclose
 
Kiwamu Okita
No Relationships to Disclose
 
Yasuaki Arai
No Relationships to Disclose